Back to resources

Thought Leadership Expertise

細胞・遺伝子治療

COO Katy Spink smiles and gestures

2020年：FDAが私たちの業界を翻弄した年（その理由）

DHC ELT + BTL Founders

BioTechLogic：最適なパートナーとの出会い

Dark Horse Consulting Group and Altruist announce a Memorandum of Understanding to advance biologics manufacturing and development in China.

Dark Horse Consulting GroupとPorton Advanced、中国におけるIIT実施の効率的なパスを提供する覚書を締結

Q&A: The Promise of Precision Medicine in Treating Ultra-rare Diseases, featuring four contributing authors from Dark Horse Consulting Group.

超希少疾患治療における精密医療の可能性

ケイティ・スピンク氏が語る、リジェネロン社のOtarmeni価格戦略とPrecision Medicine Online

Dark Horse Consulting Group and KunTuo Announce Memorandum of Understanding Providing Cell and Gene Therapy Developers with an Accelerated Path to Clinical Development in China

Dark Horse Consulting GroupとKunTuo、細胞・遺伝子治療開発企業に中国での臨床開発への加速的な道筋を提供する覚書を締結

smiling face of Katy, COO, asks the "Q" while smiling face of Don, Regulatory Master Practice Expert, gives the "A"s

ケイティとドンが語る、細胞・遺伝子治療における最近の規制動向

DHC China announcement graphic: "Providing a well-lit path to IIT in China," with a green globe centered on China.

Dark Horse Consulting Groupが中国に進出、Kang Liuをシニアディレクター兼中国代表に任命